Mesenchymal stromal cells (MSC) have been proposed as an emerging cell-based
therapeutic option for regenerative medicine applications as these cells can promote tissue …

Cell‐derived extracellular matrix (ECM) consists of a complex assembly of fibrillary proteins,
matrix macromolecules, and associated growth factors that mimic the composition and …

Regeneration of bone defects is often limited due to compromised bone tissue physiology.
Previous studies suggest that engineered extracellular matrices enhance the regenerative …

Age-related osteoporosis is driven by defects in the tissue-resident mesenchymal stromal
cells (MSCs), a heterogeneous population of musculoskeletal progenitors that includes …

With their proliferation, differentiation into specific cell types, and secretion properties,
mesenchymal stromal/stem cells (MSC) are very interesting tools to be used in regenerative …

The need for an autologous cell source for bone tissue engineering and medical
applications has led researchers to explore multipotent mesenchymal stromal cells (MSC) …

Aging at the cellular level is a complex process resulting from accumulation of various
damages leading to functional impairment and a reduced quality of life at the level of the …

Mesenchymal stem/stromal cells (MSCs) are promising cell sources for regenerative
therapies due to their multipotency and ready availability, but their application can be …

The extracellular matrix (ECM) is a dynamic component of tissue architecture that physically
supports cells and actively influences their behavior. In the context of bone regeneration, cell …

Abstract Background Mesenchymal stromal cells (MSCs) are attractive for cell-based
therapies ranging from regenerative medicine and tissue engineering to immunomodulation …